8-K
filed June 1, 2026, 7:40 PM ET
ticker LTRN
CIK 0001763950
other material
confidence low
sentiment neutral
materiality 0.50
Lantern Pharma uses presentation to discuss Harmonic Phase 2 trial of LP-300
Lantern Pharma Inc.
- Presentation furnished as Exhibit 99.1 on June 1, 2026, regarding LP-300 in Harmonic Phase 2 trial.
- No specific trial results or financial data disclosed in the 8-K filing itself.
- Investors must review the presentation exhibit for detailed clinical updates.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-026696
- form_type
- 8-K
- ticker
- LTRN
- cik
- 0001763950
- company_name
- Lantern Pharma Inc.
- filed_at
- 2026-06-01T23:40:29+00:00
- discovered_at
- 2026-06-02T10:10:00.237587+00:00
- generated_at
- 2026-06-02T10:16:21.703539+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- low
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-026696
- json_url
- https://secwatch.observer/filing/0001493152-26-026696.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-026696.md
- text_url
- https://secwatch.observer/filing/0001493152-26-026696.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1763950/000149315226026696/0001493152-26-026696-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1763950/000149315226026696/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
VTIX
Virtuix amends warrants to $4.00 exercise price, extends period to July 27, 2026
Virtuix Holdings Inc.
June 2, 2026, 9:15 AM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
OMQS
OMNIQ notes $170B in border security funding driving AI machine vision demand
OMNIQ Corp.
June 2, 2026, 8:45 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SPAI
Safe Pro receives $743K U.S. Army order for AI-powered threat analysis kit with Red Cat drones
Safe Pro Group Inc.
June 2, 2026, 8:41 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical secures first North Carolina customer for LIBERTY robotic system
Microbot Medical Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ICMB
Investcorp Credit Management BDC sells entire Work Genius position for ~$10.3M
Investcorp Credit Management BDC, Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
KIDZ
KIDZ AI pivots digital asset treasury from Solana to Hyperliquid and stablecoin yield strategies
Classover Holdings, Inc.
June 2, 2026, 8:15 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
NWE
NorthWestern Energy reaffirms 2026 non-GAAP EPS guidance $3.68-$3.83 at investor meetings
NorthWestern Energy Group, Inc.
June 2, 2026, 7:14 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BJDX
Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing
Bluejay Diagnostics, Inc.
June 2, 2026, 6:30 AM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.